Advertisement

Index by Author

February 2000; 49 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abderrahmani, A

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  2. Abusnana, S

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

B

  1. Baskin, D G

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  2. Basu, A

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  3. Basu, R

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  4. Bell, G I

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302
    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  5. Berglund, L

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  6. Berná, G

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  7. Bernasconi, L

    • Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes February 2000 49:202-208; doi:10.2337/diabetes.49.2.202

  8. Bhatti, J R

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  9. Bilinski, D

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  10. Björnholm, M

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  11. Bloom, S R

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  12. Bodelón, O G

    • Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase. Diabetes February 2000 49:209-217; doi:10.2337/diabetes.49.2.209

  13. Bonen, A

    • The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes February 2000 49:183-189; doi:10.2337/diabetes.49.2.183

  14. Bonifacio, E

    • Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes February 2000 49:202-208; doi:10.2337/diabetes.49.2.202
    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

  15. Boscá, L

    • Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase. Diabetes February 2000 49:209-217; doi:10.2337/diabetes.49.2.209

  16. Bosco, D

    • Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes February 2000 49:233-243; doi:10.2337/diabetes.49.2.233

  17. Bosi, E

    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

  18. Boss, O

    • Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes February 2000 49:143-156; doi:10.2337/diabetes.49.2.143

  19. Bouchareb-Banaei, L

    • Early pattern of differentiation in the human pancreas. Diabetes February 2000 49:225-232; doi:10.2337/diabetes.49.2.225

  20. Braghi, S

    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

C

  1. Carter, L

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  2. Castrillo, A

    • Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase. Diabetes February 2000 49:209-217; doi:10.2337/diabetes.49.2.209

  3. Chèvre, J C

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  4. Chikri, M

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  5. Ciaraldi, T P

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  6. Cox, N J

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

  7. Czernichow, P

    • Early pattern of differentiation in the human pancreas. Diabetes February 2000 49:225-232; doi:10.2337/diabetes.49.2.225

D

  1. d'Amati, G

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  2. Dallman, M F

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  3. Di Carlo, V

    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

  4. Dietze, G J

    • Insulin enhances the bradykinin response in L8 rat skeletal myoblasts. Diabetes February 2000 49:190-194; doi:10.2337/diabetes.49.2.190

  5. Dombrowski, L

    • The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes February 2000 49:183-189; doi:10.2337/diabetes.49.2.183

E

  1. Edwards, C M

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

F

  1. Fahlman, R

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  2. Fratta, L

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  3. Froguel, P

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  4. Funder-Nielsen, T

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  5. Furuta, H

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

G

  1. Galuska, D

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  2. Ghatei, M A

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

H

  1. Hagen, T

    • Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes February 2000 49:143-156; doi:10.2337/diabetes.49.2.143

  2. Hahn, T M

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  3. Halban, P A

    • Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes February 2000 49:233-243; doi:10.2337/diabetes.49.2.233

  4. Hani, E H

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  5. Hansen, L

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  6. Hansen, T

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  7. Han, X X

    • The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes February 2000 49:183-189; doi:10.2337/diabetes.49.2.183

  8. Havel, P J

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  9. Heath, M M

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  10. Heller, R S

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  11. Henry, R R

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  12. Hinokio, Y

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302
    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  13. Honda, M

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

  14. Horikawa, Y

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302
    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

I

  1. Iwamoto, Y

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

  2. Iwasaki, N

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

J

  1. Jensen, J

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  2. Jensen, M D

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  3. Jiang, X J

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  4. Johnson, C M

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

K

  1. Kim, M S

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  2. Krook, A

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  3. Kudoh, A

    • Insulin enhances the bradykinin response in L8 rat skeletal myoblasts. Diabetes February 2000 49:190-194; doi:10.2337/diabetes.49.2.190

L

  1. Lampasona, V

    • Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes February 2000 49:202-208; doi:10.2337/diabetes.49.2.202

  2. Lembo, G

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  3. Lemieux, K

    • The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes February 2000 49:183-189; doi:10.2337/diabetes.49.2.183

  4. León-Quinto, T

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  5. Lewis, G F

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  6. Lindsell, C

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  7. Lithell, H

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  8. Lowell, B B

    • Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes February 2000 49:143-156; doi:10.2337/diabetes.49.2.143

M

  1. Madsen, O D

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  2. Marette, A

    • The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes February 2000 49:183-189; doi:10.2337/diabetes.49.2.183

  3. Marino, G

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  4. Martín, F

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  5. Mathoo, J M

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  6. Meda, P

    • Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes February 2000 49:233-243; doi:10.2337/diabetes.49.2.233

  7. Mohideen, P

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  8. Morgan, D G

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  9. Moukil, M A

    • Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose. Diabetes February 2000 49:195-201; doi:10.2337/diabetes.49.2.195

  10. Mudaliar, S

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  11. Myers, M G, Jr

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

N

  1. Nair, K S

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  2. Nikoulina, S E

    • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes February 2000 49:263-271; doi:10.2337/diabetes.49.2.263

  3. Niwa, M

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

O

  1. Ogata, M

    • Beta-cell transcription factors and diabetes: no evidence for diabetes-associated mutations in the hepatocyte nuclear factor-3beta gene (HNF3B) in Japanese patients with maturity-onset diabetes of the young. Diabetes February 2000 49:302-305; doi:10.2337/diabetes.49.2.302

  2. Otabe, S

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

P

  1. Pedersen, E E

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  2. Pedersen, O

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  3. Polak, M

    • Early pattern of differentiation in the human pancreas. Diabetes February 2000 49:225-232; doi:10.2337/diabetes.49.2.225

  4. Pozza, G

    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

R

  1. Rabito, S F

    • Insulin enhances the bradykinin response in L8 rat skeletal myoblasts. Diabetes February 2000 49:190-194; doi:10.2337/diabetes.49.2.190

  2. Rashid, S

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  3. Rasmussen, S K

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  4. Reig, J A

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  5. Reneland, R

    • Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase (PPP1R3) gene and insulin sensitivity. Diabetes February 2000 49:298-301; doi:10.2337/diabetes.49.2.298

  6. Rizza, R A

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  7. Roche, E

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  8. Rossi, M

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  9. Rouiller, D G

    • Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes February 2000 49:233-243; doi:10.2337/diabetes.49.2.233

S

  1. Scharfmann, R

    • Early pattern of differentiation in the human pancreas. Diabetes February 2000 49:225-232; doi:10.2337/diabetes.49.2.225

  2. Schwartz, M W

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  3. Schwenk, W F

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  4. Seal, L J

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  5. Secchi, A

    • Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes February 2000 49:218-224; doi:10.2337/diabetes.49.2.218

  6. Serup, P

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

  7. Shah, P

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  8. Shi, Z Q

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  9. Sindelar, D K

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  10. Small, C J

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  11. Smith, D M

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  12. Soria, B

    • Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes February 2000 49:157-162; doi:10.2337/diabetes.49.2.157

  13. Stanley, S A

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

  14. Sunter, D

    • Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes February 2000 49:177-182; doi:10.2337/diabetes.49.2.177

T

  1. Trimarco, B

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  2. Trimarco, V

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

V

  1. Vandelangeryt, M L

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

  2. Van Schaftingen, E

    • Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose. Diabetes February 2000 49:195-201; doi:10.2337/diabetes.49.2.195

  3. Vaxillaire, M

    • Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians. Diabetes February 2000 49:306-308; doi:10.2337/diabetes.49.2.306

  4. Vecchione, C

    • Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes February 2000 49:293-297; doi:10.2337/diabetes.49.2.293

  5. Veiga-da-Cunha, M

    • Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose. Diabetes February 2000 49:195-201; doi:10.2337/diabetes.49.2.195

  6. Vella, A

    • Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes February 2000 49:272-283; doi:10.2337/diabetes.49.2.272

  7. Vranic, M

    • Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes February 2000 49:253-262; doi:10.2337/diabetes.49.2.253

W

  1. Wallberg-Henriksson, H

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

  2. Weigle, D S

    • Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes February 2000 49:244-252; doi:10.2337/diabetes.49.2.244

  3. Weinmaster, G

    • Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes February 2000 49:163-176; doi:10.2337/diabetes.49.2.163

Z

  1. Ziegler, A G

    • Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes February 2000 49:202-208; doi:10.2337/diabetes.49.2.202

  2. Zierath, J R

    • Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes February 2000 49:284-292; doi:10.2337/diabetes.49.2.284

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement